Spots Global Cancer Trial Database for SAS in Patients With Bronchial Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: SAS in Patients With Bronchial Carcinoma
Official Title: Incidence of Sleep Apnea Syndrome (SAS) in Patients With Bronchial Carcinoma
Study ID: NCT02270853
Interventions
Study Description
Brief Summary: In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.
Detailed Description: Determination of the SAS- frequence in patients with bronchial carcinoma. The patients will be screened at home for 1 night with the ApneaLink device by ResMed. The apneaLink device is a standard screening tool for sleep apnea in clinical practice.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Medizinische Klinik I Uniklinik RWTH Aachen, Aachen, NRW, Germany
Krankenhaus Merheim, Köln, NRW, Germany
Florence-Nightingale Hospital, Düsseldorf, , Germany
Contact Details
Name: Michael Dreher, Univ.-Prof.
Affiliation: RWTH Aachen University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
